Amid the growing importance of pneumococcal vaccination to prevent pneumonia during the change of seasons, confusion is ...

In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal serotypes causing invasive disease. [134] In the face of these changes ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

The rivalry between Pfizer and MSD in pneumococcal ... on an older polysaccharide technology that does not stimulate the immune response as strongly as the newer conjugate vaccines.

Peter H. Gilligan, Ph.D., D(ABMM) emeritus and F(AAM) was a medical microbiologist at UNC Health for 35 years. Here, he ...

Many vaccines contain trace amounts of neomycin to prevent bacterial contamination during the manufacturing process. As a topical medicament, neomycin elicits a high sensitization rate.

Doncaster and Bassetlaw Teaching Hospitals (DBTH) is encouraging those aged 65 and over to get their shingles and pneumococcal vaccines when offered, echoing the ongoing campaign by the NHS and ...

2 doses for a primary series and 1 dose as a booster, except the Omicron XBB.1.5 subvariant vaccine. Omicron XBB.1.5 subvariant vaccine doses: The Moderna Spikevax ® Bivalent COVID-19 vaccine ...

Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada (C.S., K.J.R). Centre for Infection, Immunity ...